ZBIO
Zenas BioPharma, Inc.
28.70
+0.12 (+0.42%)
52w low 13.50
44.60 high
48.9% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | -- | -- | 115.56M | 110.64M | 500.22M | 196.58M | 177.78M | |
| Current Assets | -- | -- | 296.64M | 351.17M | 730.16M | 653.79M | 603.45M | |
| Net PP&E | -- | 1.07M | 857.00K | 1.39M | 1.12M | 844.00K | -- | |
| Total Assets | -- | -- | 322.02M | 383.64M | 747.68M | 701.69M | 675.22M | |
| Current Liabilities | -- | -- | 52.42M | 62.65M | 61.16M | 65.82M | 64.04M | |
| Total Debt | -- | -- | 798.00K | 1.33M | 266.83M | 297.86M | 1.22M | |
| Total Liabilities | -- | -- | 125.59M | 141.50M | 411.85M | 454.59M | 462.91M | |
| Retained Earnings | -- | -- | -524.69M | -765.13M | -846.12M | -957.57M | -1.07B | |
| Shareholders Equity | -- | -- | 196.43M | 242.14M | 335.83M | 247.10M | 213.56M | |
| Working Capital | -- | -- | 244.22M | 288.52M | 669.00M | 587.98M | 539.40M | |
| Shares Outstanding | -- | -- | 42.21M | 54.49M | 62.38M | 63.33M | 65.18M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+900.0%